Kapitalizacja Rynkowa Zmiana Data
Acadia Pharmaceuticals USD 3.57B 100M 2026-11
ALKERMES USD 7.43B 629M 2026-11
Alnylam Pharmaceuticals USD 33.02B 7.17B 2026-09
Biogen USD 33.38B 1.48B 2026-09
BioMarin Pharmaceutical USD 10.68B 936M 2026-11
Bristol-Myers Squibb USD 127.46B 9.81B 2026-09
Cara Therapeutics USD 30M 336M 2026-03
Corcept Therapeutics USD 7.63B 4.83B 2026-11
Cytokinetics USD 7.51B 1.66B 2026-11
Eisai JPY 1.49T 73.62B 2026-11
Eli Lilly USD 1.09T 40.33B 2026-09
Incyte USD 24.6B 1.95B 2026-09
J&J USD 653.61B 42.25B 2026-09
Moderna USD 99.14B 22.26B 2026-11
Neurocrine Biosciences USD 16.38B 1.96B 2026-11
Pfizer USD 165.12B 1.71B 2026-11
Prothena USD 437M 76M 2026-11
Sarepta Therapeutics USD 1.65B 276M 2026-11
Ultragenyx Pharmaceutical USD 1.37B 108M 2026-11
Vanda Pharmaceuticals USD 279M 6M 2024-12
Vertex Pharmaceuticals USD 140.44B 7.93B 2026-11